Consequently, GLP-1 RA cessation may precipitate rapid fat regain exceeding lean mass recovery gains, exacerbating sarcopenic obesity risk especially in adults with low initial muscle reserves (Fig. 1). The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.